InvestorsHub Logo
Followers 26
Posts 2972
Boards Moderated 0
Alias Born 02/21/2007

Re: Fress post# 861

Friday, 07/03/2020 11:53:34 AM

Friday, July 03, 2020 11:53:34 AM

Post# of 36578
Dress, it looks like the drug failed because of the adverse side effects in 80% of patients. Brother we didn't get to skip Phase 2 for no reason at all. Anyone selling because of another companies bad news could miss out. There isn't many companies in the Phase 3 trials. I think we are still okay here.


https://www.clinicaltrialsarena.com/news/kevzara-us-covid19-trial-data/